SCHEMBL6538005

SCHEMBL6538005

O=c1cc[nH]c2c([N+](=O)[O-])cc(F)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR8 P51685 1/20 0.43
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 3/20 0.40
ATM Q13315 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
P2RX7 Q99572 1/20 0.37
TYMS P04818 1/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
VCAM1 P19320 1/20 0.36
CASP6 P55212 2/20 0.36
MEN1 O00255 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537755 0.83 CHUK (0.48) CCR8KMT2AALDH1A1P2RX7VCAM1
SCHEMBL6537634 0.81 GRIN2D (0.49) CCR8KMT2AALDH1A1TDP1P2RX7
SCHEMBL6537690 0.81 ALDH1A1 (0.51) CCR8KMT2AALDH1A1TDP1HSD17B10
SCHEMBL1423220 0.80 TDP1 (0.43) KMT2AALDH1A1ATMTDP1TYMS
SCHEMBL2720890 0.78 CCR8 (0.40) CCR8KMT2AALDH1A1ATMTDP1
SCHEMBL31399705 0.76 ALDH1A1 (0.59) ALDH1A1ATMTDP1TYMSHSD17B10
SCHEMBL6537493 0.76 ALDH1A1 (0.58) CCR8KMT2AALDH1A1TDP1HSD17B10
SCHEMBL22492408 0.73 CCR8 (0.48) CCR8KMT2AALDH1A1P2RX7HSD17B10
SCHEMBL20915014 0.72 ALDH1A1 (0.42) ALDH1A1ATMTDP1TYMSVCAM1
SCHEMBL22532255 0.70 CASP6 (0.50) KMT2AALDH1A1ATMTDP1P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed